Activation of the uroplakin II-specific urothelial-specific promoter in transgenic mice demonstrated the expression of SV40T antigen in the urothelium which can inactivate p53 and pRb, thereby induces the invasion of tumor and metastasis of bladder cancer. This evidence concerns the gene TP53 and urinary bladder cancer.